APPLICATIONS PUBLISHED 6 SEPTEMBER 2005
Production and purification of esters of conjugated linoleic acid
Stepan Co 1696873*
Effervescent preparation of a basic medicinal substance
Bayer HealthCare 1696874*
A method for engineering particles for use in the delivery of drugs via inhalation
Opkala, Joseph 1696875*
Buccal, polar and non-polar spray containing alprazolam
Novadel Pharma 1696876*
Methods for treating pain
The General Hospital Corp 1696877*
Ophthalmic compsns containing a polysaccharide/borate gelling system
Alcon 1696878*
Drug delivery device
Bausch & Lomb 1696879*
Drug delivery device with suture ring
Bausch & Lomb Surgical 1696880*
Stable oral compsn
Sun Pharmaceutical Industries 1696881*
Combined cases of tiotropium and fluticasone
Microdrug 1696882*
Liposomes and liposomal compsns for vaccination and drug delivery
Pharmexa 1696883*
Loading of a camptothecin drug into colloidal nanoparticles
MediGene 1696884*
Method of producing lipid complexed camptothecin-carboxylate
MediGene 1696885*
Drug delivery compsns and methods
Biotech Pharma Advisory 1696886*
Solid amorphous dispersions of an MTP inhibitor for treatment of obesity
Pfizer Products 1696887*
Process for producing pellets for pharmaceutical compsns
Temrel 1696888*
Pharmaceutical compsns of benzimidazole and processes for their preparation
Ranbaxy Laboratories 1696889*
Coated tablets containing venlaflaxin or its salts with controlled release
Zentiva 1696890*
Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
Albemarle Corp 1696891*
Device for dosing a product that is intended to be applied to the skin
Galderma 1696892*
Continuous combination therapy with selective prostaglandin EP4, receptor agonists and an estrogen for the treatment of conditions that present with low bone mass
Pfizer Products 1696893*
Treating infectious diseases using ICE inhibitors
Vertex Pharmaceuticals 1696894*
Modulation of 5-HT2 receptors as a treatment for cardiovascular diseases
Board of Regents, The University of Texas System 1696895*
The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonists, inverse agonist or partial agonist
H Lundbeck 1696896*
Compsns and methods for treating diabetes
Omega Bio-Pharma 1696897*
ZN-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors
The Ohio State University Research Foundation 1696898*
Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B
Allergan 1696899*
Use of treprostinil to treat and prevent ischaemic lesions
United Therapeutics Corp 1696900*
The use of cystine or cysteine for the prevention and treatment of oxidative stress caused by haemodialysis and of acute or chronic kidney diseases
Bio3 Research 1696901*
Compsns containing D-tocopherol compound polybasic acid partial esters
Cognis IP Management 1696902*
Combination of 2,3-dibenzylbutyrolactone and licochalcone-A
Beiersdorf 1696903*
Use of rotigotine for the treatment or prevention of dopaminergic neurone loss
Schwarz Pharma 1696904*
Use of substituted 2-aminotetralines for the preventative treatment of Parkinson's disease
Schwarz Pharma 1696905*
Novel therapeutic use of indoline derivatives
Leo Pharma 1696906*
PDK-1/AKT signaling inhibitors
The Ohio State University Research Foundation 1696907*
Use of ondansetron for the treatment of inflammation, and pharmaceutical compsns thereof
Galderma Research & Development 1696908*
Benzothiazole derivatives for the treatment of diabetes
Applied Research Systems 1696909*
Compsns and methods for treatment of fibrosis
SmithKline Beecham 1696910*
Intranasal compsns
Archimedes Development 1696911*
Pyrazolopyridines and analogs thereof
3M Innovative Properties 1696912*
Pharmaceutical compsn of vinflunine which is intended for parenteral administration method thereof and use of same
Pierre Fabre Medicament 1696913*
3-cyano-quinoline derivatives with antiproliferative activity
Janssen Pharmaceutica 1696914*
Benzensulphonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroud dehydrogenase type 1 (11-beta-HSD-1) for the treatment of diabetes and obesity
Pfizer 1696915*
Use of metabotropic glutamate receptor 5 (MGLUR5) antagonists for the treatment of gastrointestinal disorders
AstraZeneca 1696916*
Combination of (A) N-[5-[4-(4-methylpiperazino-methyl)-benzoylamido]-2-methylphenyl]-4-(3-pyridyl)-2-pyrimidine-amine and (b) at least one hypusination inhibitor and the use thereof
Novartis 1696917*
A method of treating HIV infection in atazanavir resistant patients using a combination of atazanavir and another protease inhibitor
Bristol-Myers Squibb 1696918*
3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
Incyte Corp 1696919*
Compounds and methods for development of RET modulators
Plexxikon 1696920*
Tricyclic imidazopyridines for use as gastric secretion inhibitors
Altana Pharma 1696921*
Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
Cytric Corp 1696922*
Nicotine delivery product and method for producing
Fertin Pharma 1696923*
Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies
Merck Patent 1696924*
21-heterocyclic-4-azateroid derivatives as androgen receptor modulators
Merck 1696925*
Agents for treatment of diabetic retinopathy and drusen formation in macular degeneration
Alcon 1696926*
Mitotic kinesin inhibitors
Merck 1696927*
CDK2 antagonists as short form C-MAF transcription factor antagonists for treatment of glaucoma
Alcon 1696928*
Delta-9-THC compsns and methods for treating symptoms associated with multiple sclerosis
Unimed Pharmaceuticals 1696929*
Tricyclic 1-((3-indol-3-yl)carbonyl)-piperazine derivatives as cannabinoid CB1 receptor agonists
Akzo Nobel 1696930*
Amino substituted diaryl [A,D]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
Acadia Pharmaceuticals 1696931*
Use of treprostinil to improve kidney functions
United Therapeutics 1696932*
Compsns and methods of administering tubulin binding agents for the treatment of ocular diseases
Oxigene 1696933*
Florfenicol prodrug having improved water solubility
Schering-Plough 1696934*
Novel derivatives of morphine-6-glucuronide, pharmaceutical compsns containing said derivatives, preparation method thereof and uses of same
Syntem 1696935*
Cosmetic or pharmaceutical preparations containing nucleic acid sequences forming a superstructure
Phenion 1696936*